TY - JOUR
T1 - Gene Expression Analysis for High Throughput Screening Applications
AU - Pinhasov, Albert
AU - Mei, Jay
AU - Amaratunga, Dhammika
AU - Amato, Frank A.
AU - Lu, Hong
AU - Kauffman, Jack
AU - Xin, Hong
AU - Brenneman, Douglas E.
AU - Johnson, Dana L.
AU - Andrade-Gordon, Patricia
AU - Ilyin, Sergey E.
PY - 2004/3
Y1 - 2004/3
N2 - To meet growing needs for high throughput gene expression profiling, we established a new automated high throughput TaqMan RT-PCR method for quantitative mRNA expression analysis. In this method, the AllegroTM (Zymark) system conducts all sample tracking and liquid handling steps, and ABI PRISM® 7900 HT (Applied Biosystems) is used to conduct real-time determination of the Ct value when amplification of PCR products is first detected and accumulation of inhibitory PCR products is unlikely to occur. The ABI PRISM® 7900 HT Sequence Detection System features a real-time PCR instrument with 384-well-plate compatibility and robotic loading, and continuous wavelength detection, which enables the use of multiple fluorophores in a single reaction. The Allegro System offers an assembly line approach with a modular design that allows reconfiguration of the components to accommodate variations in the assay flow. In the present study, we have established and validated a new automated High Throughput (HT) TaqMan RT-PCR-based method for quantitative mRNA expression analysis. The data demonstrate that HT-Taqman PCR is a powerful tool that can be used for measuring low concentrations of mRNA, and is highly accurate, reproducible, and amenable to high throughput analysis. Results suggest that HT-TaqMan is a reliable method for the quantification of low-expression genes and a powerful tool with HT capability for target identification/validation, structure-activity relationship (SAR) study, compound selection for efficacy studies, and biomarker identification in drug discovery and development.
AB - To meet growing needs for high throughput gene expression profiling, we established a new automated high throughput TaqMan RT-PCR method for quantitative mRNA expression analysis. In this method, the AllegroTM (Zymark) system conducts all sample tracking and liquid handling steps, and ABI PRISM® 7900 HT (Applied Biosystems) is used to conduct real-time determination of the Ct value when amplification of PCR products is first detected and accumulation of inhibitory PCR products is unlikely to occur. The ABI PRISM® 7900 HT Sequence Detection System features a real-time PCR instrument with 384-well-plate compatibility and robotic loading, and continuous wavelength detection, which enables the use of multiple fluorophores in a single reaction. The Allegro System offers an assembly line approach with a modular design that allows reconfiguration of the components to accommodate variations in the assay flow. In the present study, we have established and validated a new automated High Throughput (HT) TaqMan RT-PCR-based method for quantitative mRNA expression analysis. The data demonstrate that HT-Taqman PCR is a powerful tool that can be used for measuring low concentrations of mRNA, and is highly accurate, reproducible, and amenable to high throughput analysis. Results suggest that HT-TaqMan is a reliable method for the quantification of low-expression genes and a powerful tool with HT capability for target identification/validation, structure-activity relationship (SAR) study, compound selection for efficacy studies, and biomarker identification in drug discovery and development.
KW - Allegro
KW - Cancer
KW - Cytokines
KW - Drug Discovery
KW - Gene Expression
KW - Neurodegenerative Diseases
KW - RT-PCR
KW - Taqman
UR - http://www.scopus.com/inward/record.url?scp=11144355462&partnerID=8YFLogxK
U2 - 10.2174/138620704773120810
DO - 10.2174/138620704773120810
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 15032660
AN - SCOPUS:11144355462
SN - 1386-2073
VL - 7
SP - 133
EP - 140
JO - Combinatorial Chemistry and High Throughput Screening
JF - Combinatorial Chemistry and High Throughput Screening
IS - 2
ER -